Clinical-stage biotechnology company, California

A clinical-stage biotechnology company in California with 500 employees and $120M annual revenue faced
critical financial operational challenges that threatened regulatory compliance and cash flow management.

Financial Impact:

Legacy system caused 40% payment delays, <10% electronic payments, manual processes, poor spending visibility, and regulatory compliance risks.

Group
Vector (4)

<5%

Late payments (reduced from 40%)

Group
Vector (5)

>85%

Electronic payment adoption (increased from <10%)

Group
Vector (1)

85%+

Process automation across P2P workflows

Group
Vector (6)

100%

Regulatory compliance with full audit trails

Group
Vector (7)

Real-time

Vendor communication via centralized portal

Group
Vector (4)

<5%

Late payments (reduced from 40%)

Group
Vector (5)

>85%

Electronic payment adoption (increased from <10%)

Group
Vector (1)

85%+

Process automation across P2P workflows

Group
Vector (6)

100%

Regulatory compliance with full audit trails

Group
Vector (7)

Real-time

Vendor communication via centralized portal

Goals

Goals

  • Implement streamlined P2P processes with automated workflows
  • Transition to electronic payment systems for improved cash flow
  • Establish robust approval controls and audit capabilities
  • Create comprehensive analytics dashboard for financial insights
  • Improve communication and reduce processing friction
Our Solution

Our Solution

  • Streamlined P2P Process: Redesigned procurement-to-pay workflows with automated routing
  • Electronic Payment System: Integrated automated ACH processing and payment controls
  • Analytics Dashboard: Built real-time spending visibility and custom reporting
  • Vendor Portal: Created centralized communication hub for improved relations
  • Compliance Controls: Implemented multi-tier approvals with full audit trails
Results

Results

75% reduction in late payments (40% to <5%)

850% increase in electronic payments (10% to 95%)

85% process automation with automated
supplier follow-ups

75% reduction in maverick spending through improved controls

100% regulatory compliance achieved with full audit capabilities

Related and Recent Case Studies

Case Study

How We Eliminated 40% Payment Delays and Automated 85% of Processes for a Leading Biotech Company

Case Study

How We Reduced Reimbursement Cycles by 60% and Achieved 100% Digital Processing for a Leading Frozen Food Manufacturer

Case Study

Into a Complete Procurement Revolution: 60% Faster Processing with Zero Manual Errors

Case Study

Delivered 62% Cost Savings Through Finance Operations Outsourcing, Extending Series B Runway While Boosting Operational Excellence​

Case Study

Multiple biotech start-up companies, California, USA

Case Study

Global large pharma company, California, USA

Hear from our customers who transformed their Finance
processes with Buying Simplified

Vector
image 6

Let's Chat

Let's Chat

Scroll to Top